Axovant Sciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.12.18	EVFM Powered Up, AXON Gets A Boost, ARVN On Watch (RTTNews)
22.08.18	CVM Gearing Up For Big Event, BLFS Full Of Life, CRON Abuzz, AXON Awaits Data (RTTNews)
04.07.18	AVXL On Track, JNP Snapped Up, BLFS Hits New High, VRAY Catches Eyes (RTTNews)
07.06.18	AXON Soars On Licensing Gene Therapy, HTBX Gains Momentum, TNXP Awaits Data (RTTNews)
30.05.18	CODX Explodes, AXON Completes Restructuring, No Time To Frown For EOLS (RTTNews)
10.05.18	OPK Up 36% In 5 Days, SLDB Sparkles, CERS Abuzz, ARWR Expects Data In Nov. (RTTNews)
08.05.18	Mark Your Calendar For May 15, DXR Makes A Comeback, OBSV Abuzz, CVM On Watch (RTTNews)
16.04.18	128 Technology Teams with Arrow Electronics and Lanner to Deliver Session Smart Router Appliance (PR Newswire)
14.02.18	TYHT Shines, CATB Moves Ahead, ATRA Hits New High, CBAY Is Turning Heads (RTTNews)
12.01.18	CBMG Giving Back Its Gains, ARNA To Report Data In Q1, AXON Continues To Fall (RTTNews)
09.01.18	AXON Makes No Headway, BABY Falls, BOLD Subdued, EDIT Slips (RTTNews)
08.01.18	Axovant To Discontinue Intepirdine Program After Negative Results In Studies (RTTNews)
02.01.18	KDMN And 10 Other Biotech Stocks You Should Watch This Month (RTTNews)
14.12.17	Michael Baker International Grows Architecture Practice in Dallas with Hiring of Peter Darby to Architecture Practice Lead (PR Newswire)
27.09.17	AXON Depressed By MINDSET, CDNA On Track, PTCT On A Sticky Wicket? (RTTNews)
26.09.17	Axovant's Phase 3 Intepirdine Trial In Alzheimer's Disease Fails To Meet Goals (RTTNews)
26.09.17	Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer's Disease (PR Newswire)
21.09.17	ALNY In Top Form, LENS Catches Investors' Eyes, PRQR, AXON Inch Closer To D-Day (RTTNews)
18.09.17	Keep An Eye On These Biotech Stocks This Month, If Invested (RTTNews)
12.09.17	Alzheimer's Disease: Cannabis Formulation Shows Promise (PR Newswire)
12.09.17	Alzheimer's Disease: Cannabis Formulation Shows Promise (PR Newswire)
06.09.17	Axovant to Present at Two Upcoming Investor Conferences (PR Newswire)
22.08.17	FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed (RTTNews)
17.08.17	Race For A New Alzheimer's Drug (RTTNews)
09.08.17	Daily Technical Summary Reports on Biotech Stocks -- Axovant Sciences, Ampio Pharma, ImmunoCellular Therapeutics, and Synthetic Biologics (PR Newswire)
07.08.17	Axovant Announces Fiscal First Quarter Financial Results and Corporate Updates (PR Newswire)
19.07.17	New Preclinical Data for Intepirdine Suggests Potential Neuroprotective Properties (PR Newswire)
10.07.17	Dermavant Sciences Appoints Dr. Jacqualyn Fouse as Executive Chairman (PR Newswire)
10.07.17	Axovant to Present Key Intepirdine and Nelotanserin Data at Alzheimer's Association International Conference (PR Newswire)
30.06.17	Biotech Stock Performance Review -- Vertex Pharma, VIVUS, Xbiotech, and Axovant Sciences (PR Newswire)
19.06.17	FDA Grants Fast Track Designation to Axovant's Nelotanserin for Visual Hallucinations in Dementia with Lewy Bodies (PR Newswire)
15.06.17	Pharmaceutical Leaders Pave the Way to New Alzheimer's Treatments (PR Newswire)
15.06.17	Pharmaceutical Leaders Pave the Way to New Alzheimer's Treatments (PR Newswire)
13.06.17	Axovant Sciences Announces Fiscal Year-End Financial Results and Corporate Updates (PR Newswire)
06.06.17	Axovant Announces Changes to Board of Directors (PR Newswire)
06.06.17	Axovant Strengthens Executive Team with Key Management Appointments (PR Newswire)
31.05.17	Axovant Sciences to Present at Upcoming Investor Conferences (PR Newswire)
21.04.17	Company Spotlight: Axovant Sciences (RTTNews)
17.04.17	Axovant Sciences Ltd. Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares (PR Newswire)
11.04.17	Axovant Sciences Ltd. Announces Pricing of $125M Public Offering of Common Shares (PR Newswire)
11.04.17	AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA (RTTNews)
11.04.17	Gainers & Losers Of Apr.10: CYTX, AXON, GERN, OMED, TXMD... (RTTNews)
10.04.17	Axovant Sciences Ltd. Announces $100 Million Public Offering of Common Shares (PR Newswire)
10.04.17	Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors (PR Newswire)
21.03.17	Axovant Sciences to Present at Upcoming Scientific Meetings (PR Newswire)
20.03.17	Axovant Sciences Announces Presentation Time Change at Oppenheimer Healthcare Conference (PR Newswire)
27.02.17	Axovant Sciences to Present at Upcoming Investor Conferences (PR Newswire)
15.02.17	AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO (RTTNews)
14.02.17	Axovant Sciences Announces Dementia Pipeline Updates and Reports Financial Results for the Third Fiscal Quarter and Nine Months Ended December 31, 2016 (PR Newswire)
13.02.17	Axovant Sciences Announces Preliminary Results from Interim Analysis of Phase 2 Study Testing Investigational Drug Nelotanserin in Lewy Body Dementia Patients (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	82.24	2.93 %	K V
Part Grp Hldg	1’404.00	1.67 %	K V
CieFinRichemont	170.10	1.10 %	K V
Kuehne+Nagel Int	206.60	0.98 %	K V
Holcim	89.82	0.92 %	K V
ABB	53.58	0.04 %	K V
Givaudan	3’941.00	-0.10 %	K V
Geberit	498.50	-0.46 %	K V
Alcon	80.46	-0.54 %	K V
Sonova Hldg	314.80	-1.16 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Axovant Sciences Ltd

Aktien Top/Flop

Meistgelesene Nachrichten